Key result
Depression is linked to lower COPD treatment adherence, while anxiety shows a weak association.
Why the study?
Almost half of patients with COPD do not adhere to treatments and report comorbid anxiety and depression, but a synthesized evaluation of the relationships between anxiety, depression, and treatment adherence in COPD was needed.
What is the relationship between anxiety, depression, and treatment adherence in people with COPD?
Systematic Review
What is the relationship between anxiety, depression, and treatment adherence in people with COPD?
Depression is significantly and negatively associated with treatment adherence in COPD patients, highlighting the importance of addressing psychological comorbidities to improve clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Addressing depression may improve adherence in COPD; confirms consistent negative link across studies while anxiety effects remain variable.
Volpato et al. (2021) conducted a systematic review in Chronic Obstructive Pulmonary Disease (COPD). Anxiety and depression (exposures) was evaluated on Treatment adherence. Depression across 34 reviewed studies had a significant negative relationship with treatment adherence in COPD, while the association with anxiety was weak and highly variable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: